Ukuguqulwa okusha kwe-COVID 'arcturus' kubangela izimpawu ezihlukene ezinganeni

I-TAMPA.Abacwaningi okwamanje baqapha okuhlukile kwe-micromicron virus COVID-19 XBB.1.16, eyaziwa nangokuthi i-arcturus.

"Izinto zibonakala ziba ngcono kancane," kusho uDkt. Michael Teng, udokotela wezifo ezithathelwanayo kanye noprofesa ohlangene wezempilo yomphakathi e-USF.
"Kwangithinta ngempela ngoba leli gciwane cishe seliyigciwane elithathelwana kakhulu elaziwa umuntu. Ngakho-ke angiqiniseki ngempela ukuthi lokhu kuzophela nini," kusho uDkt. Thomas Unnash, umcwaningi nochwepheshe bezempilo yomphakathi.
I-Arcturus inesibopho sokukhuphuka kwamanje ezimweni zaseNdiya, ezibika amacala amasha ayi-11,000 nsuku zonke.
IWorld Health Organisation isimemezele ukuthi ilandela umkhondo we-subvariant ngoba njengamanje itholakala emazweni amaningi.Ezinye izimo ziye zatholakala e-United States.Ngokusho kwedatha yakamuva evela kwa-CDC, ibala cishe u-7.2% wamacala amasha.

“Ngicabanga ukuthi sizobona ukukhula futhi ngicabanga ukuthi mhlawumbe sizobona okufanayo nalokhu abakubona eNdiya,” kusho unnash.Kodwa-ke, bathola ukuthi kuthinte izingane eziningi, okubangela izimpawu ezihlukile kwezinye izinguquko, okuhlanganisa ukwanda kwe-conjunctivitis kanye nomkhuhlane ophezulu.

“Akukhona ukuthi besingakaze simbone.Kwenzeka kaningi,” kusho uTen.
Izikhulu zezempilo zithi njengoba igundane elinezimpondo liqhubeka nokusabalala, silindele ukuthi izingane eziningi zitheleleke.
“Ngicabanga ukuthi enye into okungenzeka ukuthi siyibona eNdiya wubufakazi bokuqala bokuthi lesi kungaba yisifo sezingane.Yilapho amagciwane amaningi egcina khona,” kusho u-Unnash.
Inketho encane yenzeke lapho i-FDA isanda kubuyekeza isiqondiso sayo semithi yokugomela i-bivalent, eyivumela yonke imithamo enikezwa abantu abanezinyanga eziyisithupha nangaphezulu, okuhlanganisa imithamo eyengeziwe yabantu abathile.
Imihlahlandlela emisha ifaka isincomo sokuthi abantu abaneminyaka yobudala engama-65 nangaphezulu bathole umthamo wesibili womuthi wokugomela i-bivalent ezinyangeni ezine ngemuva komthamo wokuqala.
I-FDA futhi manje isincoma ukuthi abantu abaningi abangenawo amandla omzimba bathole imithamo eyengeziwe okungenani izinyanga ezimbili ngemuva komthamo wokuqala womgomo we-bivalent.
“Njengoba sikhathazekile ngokwanda kokutheleleka ngezifo ezihlukahlukene ezithathelwanayo, manje yisikhathi sokuqala ukwakha amasosha omzimba wakho ukuze lapho sibona amacala amaningi alokhu kuhluka okusha, wazi ukuthi amasosha akho omzimba azobe ekulungele ukulwa nawo. ," kusho uTan.